Please provide your email address to receive an email when new articles are posted on . Sozinibercept, a VEGF-C and -D “trap” inhibitor, showed improved durability in patients with retinal diseases ...

Please provide your email address to receive an email when new articles are posted on . ROME — A deep learning algorithm developed at University of California, Los Angeles, showed superior performance ...

The therapy is expected to block abnormal blood vessel growth, limit vascular leakage, and reduce retina damage. The Food and Drug Administration (FDA) has granted Fast Track designation to SAR402663 ...

—The findings about the diagnostic accuracy of the Amsler grid test for early detection of neovascular age-related macular degeneration suggest that the procedure will not replace regular ophthalmic ...

People who take the oral biguanide metformin have a 5% lower odds of developing age-related macular degeneration (AMD) than people who do not use the diabetes drug. The study included 86,930 patients ...

Arshad M. Khanani, MD, reflects on updates he has integrated into his practice following insights from the AAO 2024 annual meeting's retina subspecialty day. Dr Khanani highlights recent research on ...

Safety Review Committee (SRC) approves single ascending dose 4mg cohort in Phase 1 trial of PMC-403, preparing for multiple ascending dose 4 mg cohort. PMC-403 is being explored in broader therapeutic ...

Three at-home vision-monitoring tools failed to detect worsening neovascular age-related macular degeneration (AMD), a diagnostic-test accuracy study reported. The paper-based KeepSight Journal from ...

Lotery cautioned that AI's use in eye care has limitations. "AI models may underperform on underrepresented populations, AI trained on specific datasets may not transfer well across clinical settings, ...

Designation earned for a one-time intravitreal gene therapy with the potential to eliminate treatment burden for people living with neovascular age-related macular degeneration Neovascular or “wet” ...